Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 150

1.

Concomitant etodolac affects neither the unbound clearance nor the pharmacologic effect of warfarin.

Ermer JC, Hicks DR, Wheeler SC, Kraml M, Jusko WJ.

Clin Pharmacol Ther. 1994 Mar;55(3):305-16.

PMID:
8143396
2.

Norfloxacin does not alter warfarin's disposition or anticoagulant effect.

Rocci ML Jr, Vlasses PH, Distlerath LM, Gregg MH, Wheeler SC, Zing W, Bjornsson TD.

J Clin Pharmacol. 1990 Aug;30(8):728-32.

PMID:
2401751
3.

Interaction between warfarin and propafenone in healthy volunteer subjects.

Kates RE, Yee YG, Kirsten EB.

Clin Pharmacol Ther. 1987 Sep;42(3):305-11.

PMID:
3621785
4.

Pharmacokinetic interaction between warfarin and a uricosuric agent, bucolome: application of In vitro approaches to predicting In vivo reduction of (S)-warfarin clearance.

Takahashi H, Kashima T, Kimura S, Murata N, Takaba T, Iwade K, Abe T, Tainaka H, Yasumori T, Echizen aH.

Drug Metab Dispos. 1999 Oct;27(10):1179-86.

5.

Losartan does not affect the pharmacokinetics and pharmacodynamics of warfarin.

Kong AN, Tomasko L, Waldman SA, Osborne B, Deutsch PJ, Goldberg MR, Bjornsson TD.

J Clin Pharmacol. 1995 Oct;35(10):1008-15.

PMID:
8568008
6.

Evaluation of a potential tigecycline-warfarin drug interaction.

Zimmerman JJ, Raible DG, Harper DM, Matschke K, Speth JL.

Pharmacotherapy. 2008 Jul;28(7):895-905. doi: 10.1592/phco.28.7.895.

PMID:
18576904
7.

Further elucidation of pharmacokinetic interaction between diltiazem and warfarin.

Stoysich AM, Lucas BD, Mohiuddin SM, Hilleman DE.

Int J Clin Pharmacol Ther. 1996 Feb;34(2):56-60.

PMID:
8929747
8.

Celecoxib does not significantly alter the pharmacokinetics or hypoprothrombinemic effect of warfarin in healthy subjects.

Karim A, Tolbert D, Piergies A, Hubbard RC, Harper K, Wallemark CB, Slater M, Geis GS.

J Clin Pharmacol. 2000 Jun;40(6):655-63.

PMID:
10868317
9.

Effect of montelukast on the pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers.

Van Hecken A, Depré M, Verbesselt R, Wynants K, De Lepeleire I, Arnout J, Wong PH, Freeman A, Holland S, Gertz B, De Schepper PJ.

J Clin Pharmacol. 1999 May;39(5):495-500.

PMID:
10234597
10.

No pharmacokinetic or pharmacodynamic interaction between rivastatin and warfarin.

Schall R, Müller FO, Hundt HK, Ritter W, Duursema L, Groenewoud G, Middle MV.

J Clin Pharmacol. 1995 Mar;35(3):306-13.

PMID:
7608323
11.

Absence of an effect of levofloxacin on warfarin pharmacokinetics and anticoagulation in male volunteers.

Liao S, Palmer M, Fowler C, Nayak RK.

J Clin Pharmacol. 1996 Nov;36(11):1072-7.

PMID:
8973996
12.

Population differences in S-warfarin metabolism between CYP2C9 genotype-matched Caucasian and Japanese patients.

Takahashi H, Wilkinson GR, Caraco Y, Muszkat M, Kim RB, Kashima T, Kimura S, Echizen H.

Clin Pharmacol Ther. 2003 Mar;73(3):253-63.

PMID:
12621390
14.

Lack of effect of repeated administration of levetiracetam on the pharmacodynamic and pharmacokinetic profiles of warfarin.

Ragueneau-Majlessi I, Levy RH, Meyerhoff C.

Epilepsy Res. 2001 Nov;47(1-2):55-63.

PMID:
11673021
15.

Developmental changes in pharmacokinetics and pharmacodynamics of warfarin enantiomers in Japanese children.

Takahashi H, Ishikawa S, Nomoto S, Nishigaki Y, Ando F, Kashima T, Kimura S, Kanamori M, Echizen H.

Clin Pharmacol Ther. 2000 Nov;68(5):541-55.

PMID:
11103757
16.

Determination of the interaction of 3S-hydroxy-10,11-dihydroquinidine on the pharmacokinetics and pharmacodynamics of warfarin.

Trenk D, Möhrke W, Warth L, Jähnchen E.

Arzneimittelforschung. 1993 Aug;43(8):836-41.

PMID:
8216438
17.
18.

Effect of rutin on warfarin anticoagulation and pharmacokinetics of warfarin enantiomers in rats.

Chan E, Hegde A, Chen X.

J Pharm Pharmacol. 2009 Apr;61(4):451-8. doi: 10.1211/jpp/61.04.0006.

PMID:
19298691
19.

The effect of cimetidine on the steady-state pharmacokinetics and pharmacodynamics of warfarin in humans.

Niopas I, Toon S, Aarons L, Rowland M.

Eur J Clin Pharmacol. 1999 Jul;55(5):399-404.

PMID:
10456491
20.

Stereochemical aspects of warfarin drug interactions: use of a combined pharmacokinetic-pharmacodynamic model.

Chan E, McLachlan A, O'Reilly R, Rowland M.

Clin Pharmacol Ther. 1994 Sep;56(3):286-94.

PMID:
7924124

Supplemental Content

Support Center